Platelet-derived chemokines in vascular remodeling and atherosclerosis

Seminars in Thrombosis and Hemostasis

Volumn 36, Issue 2, 2010, Pages 163-169

  Koenen, Rory R ^a,b   Weber, Christian ^a,b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Chemokines; Endothelium; Platelets; Vascular inflammation

Indexed keywords

CD147 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR4; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; P SELECTIN GLYCOPROTEIN LIGAND 1; RANTES; STROMAL CELL DERIVED FACTOR 1; STROMAL CELL DERIVED FACTOR 1ALPHA;

ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; HEART VENTRICLE REMODELING; HEMOSTASIS; HUMAN; HYPERPLASIA; IMMUNOCOMPETENT CELL; INFLAMMATION; INTIMA; LEUKOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE; THROMBOCYTE ADHESION; VASCULITIS;

ATHEROSCLEROSIS; BLOOD PLATELETS; BLOOD VESSELS; CHEMOKINES; HUMANS; INFLAMMATION;

EID: 77951592348     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0030-1251500     Document Type: Review

References (73)

1. Battinelli E M., Hartwig J H., Italiano J E. Jr. Delivering new insight into the biology of megakaryopoiesis and thrombopoiesis. Curr Opin Hematol 2007 14 (5) 419-426
2. Junt T, Schulze H, Chen Z et al. Dynamic visualization of thrombopoiesis within bone marrow. Science 2007 317 (5845) 1767-1770 (Pubitemid 47461844)
3. Jurk K, Kehrel B E. Platelets: Physiology and biochemistry. Semin Thromb Hemost 2005 31 (4) 381-392 (Pubitemid 41362342)
4. Varga-Szabo D, Pleines I, Nieswandt B. Cell adhesion mechanisms in platelets. Arterioscler Thromb Vasc Biol 2008 28 (3) 403-412
5. Cosemans J M., Iserbyt B F., Deckmyn H, Heemskerk J W. Multiple ways to switch platelet integrins on and off. J Thromb Haemost 2008 6 (8) 1253-1261 (Pubitemid 352016302)
6. Lindemann S, Tolley N D., Dixon D A. et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol 2001 154 (3) 485-490 (Pubitemid 34286155)
7. Lindemann S, Gawaz M. The active platelet: translation and protein synthesis in an anucleate cell. Semin Thromb Hemost 2007 33 (2) 144-150 (Pubitemid 46427756)
8. Mason K D., Carpinelli M R., Fletcher J I. et al. Programmed anuclear cell death delimits platelet life span. Cell 2007 128 (6) 1173-1186
9. Zhang H, Nimmer P M., Tahir S K. et al. Bcl-2 family proteins are essential for platelet survival. Cell Death Differ 2007 14 (5) 943-951 (Pubitemid 46655455)
10. May A E., Seizer P, Gawaz M. Platelets: inflammatory firebugs of vascular walls. Arterioscler Thromb Vasc Biol 2008 28 (3) s5-s10
11. von Hundelshausen P, Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res 2007 100 (1) 27-40 (Pubitemid 46066771)
12. Weyrich A S., Zimmerman G A. Platelets: signaling cells in the immune continuum. Trends Immunol 2004 25 (9) 489-495
13. von Hundelshausen P, Petersen F, Brandt E. Platelet-derived chemokines in vascular biology. Thromb Haemost 2007 97 (5) 704-713 (Pubitemid 46804313)
14. Von Hundelshausen P, Koenen R R., Weber C. Platelet-mediated enhancement of leukocyte adhesion. Microcirculation 2009 16 84-96
15. Gawaz M, Langer H, May A E. Platelets in inflammation and atherogenesis. J Clin Invest 2005 115 (12) 3378-3384 (Pubitemid 43121822)
16. van Gils J M., Zwaginga J J., Hordijk P L. Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases. J Leukoc Biol 2009 85 (2) 195-204
17. Morel O, Toti F, Hugel B et al. Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol 2006 26 (12) 2594-2604
18. Mause S F., von Hundelshausen P, Zernecke A, Koenen R R., Weber C. Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol 2005 25 (7) 1512-1518 (Pubitemid 40923377)
19. Frenette P S., Denis C V., Weiss L et al. P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J Exp Med 2000 191 (8) 1413-1422 (Pubitemid 30227127)
20. Frenette P S., Johnson R C., Hynes R O., Wagner D D. Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proc Natl Acad Sci U S A 1995 92 (16) 7450-7454
21. Massberg S, Enders G, Leiderer R et al. Platelet-endothelial cell interactions during ischemia/reperfusion: the role of P-selectin. Blood 1998 92 (2) 507-515 (Pubitemid 28323713)
22. Romo G M., Dong J F., Schade A J. et al. The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin. J Exp Med 1999 190 (6) 803-814
23. da Costa Martins P, Garca-Vallejo J J., van Thienen J V. et al. P-selectin glycoprotein ligand-1 is expressed on endothelial cells and mediates monocyte adhesion to activated endothelium. Arterioscler Thromb Vasc Biol 2007 27 (5) 1023-1029 (Pubitemid 46641987)
24. Yan L, Zucker S, Toole B P. Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression. Thromb Haemost 2005 93 (2) 199-204 (Pubitemid 40253722)
25. Schmidt R, Bltmann A, Fischel S et al. Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes. Circ Res 2008 102 (3) 302-309 (Pubitemid 351271650)
26. Seizer P, Borst O, Langer H F. et al. EMMPRIN (CD147) is a novel receptor for platelet GPVI and mediates platelet rolling via GPVI-EMMPRIN interaction. Thromb Haemost 2009 101 (4) 682-686
27. Kato N, Yuzawa Y, Kosugi T et al. The E-selectin ligand basigin/CD147 is responsible for neutrophil recruitment in renal ischemia/reperfusion. J Am Soc Nephrol 2009 20 (7) 1565-1576
28. Gawaz M, Neumann F J., Dickfeld T et al. Vitronectin receptor (alpha(v)beta3) mediates platelet adhesion to the luminal aspect of endothelial cells: implications for reperfusion in acute myocardial infarction. Circulation 1997 96 (6) 1809-1818 (Pubitemid 27400738)
29. Bombeli T, Schwartz B R., Harlan J M. Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha. J Exp Med 1998 187 (3) 329-339 (Pubitemid 28080062)
30. Andr P, Denis C V., Ware J et al. Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins. Blood 2000 96 (10) 3322-3328
31. Jurk K, Clemetson K J., de Groot P G. et al. Thrombospondin-1 mediates platelet adhesion at high shear via glycoprotein Ib (GPIb): an alternative/backup mechanism to von Willebrand factor. FASEB J 2003 17 (11) 1490-1492
32. Weber C, Fraemohs L, Dejana E. The role of junctional adhesion molecules in vascular inflammation. Nat Rev Immunol 2007 7 (6) 467-477 (Pubitemid 46834851)
33. Babinska A, Kedees M H., Athar H et al. F11-receptor (F11R/JAM) mediates platelet adhesion to endothelial cells: role in inflammatory thrombosis. Thromb Haemost 2002 88 (5) 843-850 (Pubitemid 35350778)
34. Ostermann G, Fraemohs L, Baltus T et al. Involvement of JAM-A in mononuclear cell recruitment on inflamed or atherosclerotic endothelium: inhibition by soluble JAM-A. Arterioscler Thromb Vasc Biol 2005 25 (4) 729-735 (Pubitemid 40463861)
35. Babinska A, Azari B M., Salifu M O. et al. The F11 receptor (F11R/JAM-A) in atherothrombosis: overexpression of F11R in atherosclerotic plaques. Thromb Haemost 2007 97 (2) 272-281 (Pubitemid 46592148)
36. Henn V, Slupsky J R., Gräfe M et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998 391 (6667) 591-594 (Pubitemid 28157601)
37. Gawaz M, Brand K, Dickfeld T et al. Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis. Atherosclerosis 2000 148 (1) 75-85
38. Massberg S, Brand K, Grner S et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 2002 196 (7) 887-896
39. Theilmeier G, Michiels C, Spaepen E et al. Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia. Blood 2002 99 (12) 4486-4493 (Pubitemid 34627218)
40. Huo Y, Schober A, Forlow S B. et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2003 9 (1) 61-67 (Pubitemid 36098261)
41. Dole V S., Bergmeier W, Mitchell H A., Eichenberger S C., Wagner D D. Activated platelets induce Weibel-Palade-body secretion and leukocyte rolling in vivo: role of P-selectin. Blood 2005 106 (7) 2334-2339 (Pubitemid 41510804)
42. Wang Y, Sakuma M, Chen Z et al. Leukocyte engagement of platelet glycoprotein Ibalpha via the integrin Mac-1 is critical for the biological response to vascular injury. Circulation 2005 112 (19) 2993-3000 (Pubitemid 41612303)
43. Santoso S, Sachs U J., Kroll H et al. The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1. J Exp Med 2002 196 (5) 679-691 (Pubitemid 35024445)
44. Langer H F., Daub K, Braun G et al. Platelets recruit human dendritic cells via Mac-1/JAM-C interaction and modulate dendritic cell function in vitro. Arterioscler Thromb Vasc Biol 2007 27 (6) 1463-1470 (Pubitemid 46809439)
45. Hristov M, Zernecke A, Liehn E A., Weber C. Regulation of endothelial progenitor cell homing after arterial injury. Thromb Haemost 2007 98 (2) 274-277 (Pubitemid 47250227)
46. Langer H, May A E., Daub K et al. Adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells to mature endothelial cells in vitro. Circ Res 2006 98 (2) e2-e10 (Pubitemid 43755340)
47. Schober A. Chemokines in vascular dysfunction and remodeling. Arterioscler Thromb Vasc Biol 2008 28 (11) 1950-1959
48. Ceradini D J., Kulkarni A R., Callaghan M J. et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004 10 (8) 858-864
49. Schober A, Knarren S, Lietz M, Lin E A., Weber C. Crucial role of stromal cell-derived factor-1alpha in neointima formation after vascular injury in apolipoprotein E-deficient mice. Circulation 2003 108 (20) 2491-2497 (Pubitemid 37444411)
50. Zernecke A, Schober A, Bot I et al. SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ Res 2005 96 (7) 784-791 (Pubitemid 40559518)
51. Karshovska E, Zernecke A, Sevilmis G et al. Expression of HIF-1alpha in injured arteries controls SDF-1alpha mediated neointima formation in apolipoprotein E deficient mice. Arterioscler Thromb Vasc Biol 2007 27 (12) 2540-2547 (Pubitemid 350158903)
52. Jin D K., Shido K, Kopp H G. et al. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med 2006 12 (5) 557-567
53. Massberg S, Konrad I, Schrzinger K et al. Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med 2006 203 (5) 1221-1233 (Pubitemid 43736592)
54. Stellos K, Langer H, Daub K et al. Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells. Circulation 2008 117 (2) 206-215
55. Hristov M, Zernecke A, Bidzhekov K et al. Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury. Circ Res 2007 100 (4) 590-597 (Pubitemid 46673269)
56. von Hundelshausen P, Weber K S., Huo Y et al. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 2001 103 (13) 1772-1777 (Pubitemid 32291415)
57. Baltus T, von Hundelshausen P, Mause S F., Buhre W, Rossaint R, Weber C. Differential and additive effects of platelet-derived chemokines on monocyte arrest on inflamed endothelium under flow conditions. J Leukoc Biol 2005 78 (2) 435-441 (Pubitemid 41061315)
58. Schober A, Manka D, von Hundelshausen P et al. Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury. Circulation 2002 106 (12) 1523-1529
59. Zernecke A, Liehn E A., Fraemohs L et al. Importance of junctional adhesion molecule-A for neointimal lesion formation and infiltration in atherosclerosis-prone mice. Arterioscler Thromb Vasc Biol 2006 26 (2) e10-e13 (Pubitemid 43732185)
60. Veillard N R., Kwak B, Pelli G et al. Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice. Circ Res 2004 94 (2) 253-261 (Pubitemid 38197459)
61. Braunersreuther V, Zernecke A, Arnaud C et al. Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2007 27 (2) 373-379 (Pubitemid 46143054)
62. Sachais B S., Turrentine T, Dawicki McKenna J M., Rux A H., Rader D, Kowalska M A. Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in C57Bl/6 and apoE-/- mice. Thromb Haemost 2007 98 (5) 1108-1113 (Pubitemid 350091140)
63. Simeoni E, Winkelmann B R., Hoffmann M M. et al. Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis. Eur Heart J 2004 25 (16) 1438-1446 (Pubitemid 39078251)
64. Bger C A., Fischereder M, Deinzer M et al. RANTES gene polymorphisms predict all-cause and cardiac mortality in type 2 diabetes mellitus hemodialysis patients. Atherosclerosis 2005 183 (1) 121-129 (Pubitemid 41416830)
65. von Hundelshausen P, Koenen R R., Sack M et al. Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood 2005 105 (3) 924-930 (Pubitemid 40170856)
66. Koenen R R., von Hundelshausen P, Nesmelova I V. et al. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat Med 2009 15 (1) 97-103
67. Combadire C, Potteaux S, Rodero M et al. Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 2008 117 (13) 1649-1657 (Pubitemid 351482605)
68. Johnson Z, Kosco-Vilbois M H., Herren S et al. Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system. J Immunol 2004 173 (9) 5776-5785 (Pubitemid 39392167)
69. Braunersreuther V, Steffens S, Arnaud C et al. A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice. Arterioscler Thromb Vasc Biol 2008 28 (6) 1090-1096
70. Anders H J., Frink M, Linde Y et al. CC chemokine ligand 5/RANTES chemokine antagonists aggravate glomerulonephritis despite reduction of glomerular leukocyte infiltration. J Immunol 2003 170 (11) 5658-5666 (Pubitemid 36617858)
71. Srensen L N., Paludan S R. Blocking CC chemokine receptor (CCR) 1 and CCR5 during herpes simplex virus type 2 infection in vivo impairs host defence and perturbs the cytokine response. Scand J Immunol 2004 59 (3) 321-333
72. Karshovska E, Zagorac D, Zernecke A, Weber C, Schober A. A small molecule CXCR4 antagonist inhibits neointima formation and smooth muscle progenitor cell mobilization after arterial injury. J Thromb Haemost 2008 6 (10) 1812-1815
73. Zernecke A, Bot I, Djalali-Talab Y et al. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ Res 2008 102 (2) 209-217 (Pubitemid 351651125)